Purchase Order 75N95020P00529
- Not listed
- This federal contract award is for $143,850.00 to Novogene Corp Inc., a minority-owned small business, by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse. The contract is a firm fixed price purchase order for genomic sequencing and bioinformatics services to support biomedical research. Novogene has previously received over 100 prime contracts from federal agencies including the NIH, Department of Veterans Affairs, Department of...
- This is a firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Novogene Corp Inc., a minority-owned small business. The contract, valued at $13,748.40, is for RNA sample quality control services. No set-aside was used. Novogene is a provider of next-generation sequencing and bioinformatics services, and has established a significant relationship with federal agencies through numerous prime contract and...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...
- Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order contract valued at $24,350 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for laboratory testing services to support genomic sequencing and bioinformatics research efforts. Specifically, Novogene will provide DNA/RNA sample sequencing and data analysis services leveraging Illumina and PacBio platforms, including whole...
- This is a $25,000 Firm Fixed Price purchase order awarded by the National Institute of Mental Health (NIMH) to Novogene Corporation Inc., a minority-owned small business in Sacramento, California. The contract is not set aside. Novogene is providing advanced genomic sequencing and bioinformatics services to support NIMH's scientific research programs. This includes services such as whole genome, transcriptome, metagenomic, and RNA sequencing. Novogene has previously secured multiple federal...
- This is a $13,400 firm fixed-price purchase order contract awarded by the National Eye Institute, a civilian agency within the National Institutes of Health, to Novogene Corp Inc., a minority-owned small business. The contract is for cell handling and sequencing services, with a period of performance through September 30, 2024. Novogene is a genomics services provider that specializes in next-generation DNA and RNA sequencing, bioinformatics, and research support for federal agencies across...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The $11,766 contract is for sequencing and analysis services to be provided by Novogene Corp Inc., a minority-owned small business. The services include next-generation sequencing of DNA and RNA samples, library preparation, and associated bioinformatics analysis. This contract is not designated as...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging, a civilian federal agency, to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract is for $21,800 and covers laboratory and testing services, specifically strand-specific mRNA sequencing and bioinformatics analysis, with a period of performance through March 31, 2026. Novogene has an established track record of providing advanced genomic sequencing...
- This is a $16,056 Firm Fixed Price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian agency, to Novogene Corp Inc., a minority-owned small business, for ATAC sequencing of 24 neuronal cell line samples. The work will be performed in Sacramento, CA and the ultimate completion date is May 20, 2025. Novogene is a provider of next-generation sequencing services to various federal agencies, including the NIH, VA, USDA, NOAA, and USGS. This award does not utilize a...
- This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...
This federal contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Novogene Corp Inc., a minority-owned small business. The $151,346.44 firm fixed price purchase order is to perform quality control on de-identified DNA and RNA samples. This work supports NIH's ongoing research into the genetic basis of mood and anxiety disorders, as it will enable whole genome, whole exome, and RNA sequencing of samples collected from individuals with these conditions and their family members. Novogene has extensive experience providing sequencing and bioinformatics services to the federal government, having received over 100 prime contracts from NIH, the Department of Veterans Affairs, Department of Agriculture, and other agencies since 2015. The contract has a small business set-aside designation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Next Generation Sequencing (NGS) in Psychiatric Disorders | NIMH-20-004388 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/1 | 8/14/20, 9:49 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 6/15/22 | |
| P00001 | Exercise an Option | $48.7k | 8/9/21 | |
| Not listed | Not listed | $102.6k | 9/17/20 |